Citation | Cadilla, R; Deaton, DN; Do, Y; Elkins, PA; Ennulat, D; Guss, JH; Holt, J; Jeune, MR; King, AG; Klapwijk, JC; Kramer, HF; Kramer, NJ; Laffan, SB; Masuria, PI; McDougal, AV; Mortenson, PN; Musetti, C; Peckham, GE; Pietrak, BL; Poole, C; Price, DJ; Rendina, AR; Sati, G; Saxty, G; Shearer, BG; Shewchuk, LM; Sneddon, HF; Stewart, EL; Stuart, JD; Thomas, DN; Thomson, SA; Ward, P; Wilson, JW; Xu, T; Youngman, MA The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure. Bioorg Med Chem28:0 (2020) [PubMed] |
---|
SMILES | C[C@@]1(O)C[C@@H](C1)NC(=O)c1cnc2cc(ncc2c1)N1CCC1 |r,wU:4.6,1.1,(7.22,3.52,;6.45,2.19,;7.99,2.19,;4.96,2.58,;4.55,1.07,;6.04,.67,;3.22,.3,;1.89,1.07,;1.89,2.61,;.55,.3,;.55,-1.24,;-.78,-2,;-2.11,-1.23,;-3.43,-2,;-4.76,-1.24,;-4.76,.29,;-3.45,1.06,;-2.11,.3,;-.79,1.08,;-6.1,-2.01,;-6.5,-3.52,;-7.99,-3.12,;-7.58,-1.61,)| |